Filing Details

Accession Number:
0001181431-11-040054
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-07-06 11:25:54
Reporting Period:
2011-07-01
Filing Date:
2011-07-06
Accepted Time:
2011-07-06 11:25:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Vermillion Inc. VRML In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1487732 B. William Creech C/O Vermillion, Inc. 12117 Bee Caves Rd
Building Two, Suite 100
Austin TX 78738
Vp Sales And Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-07-01 489 $4.04 22,463 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2011.